Over the short break that divided 2013 and 2014, we had a new study published looking at the designs of neuropsychiatric clinical trials that involve children. Because we study trial registrations and not publications, many of the trials that are included in the study are yet to be published, and it is likely that quite a … Continue reading Neuropsych trials involving kids are designed differently when funded by the companies that make the drugs
I asked a question on Twitter about whether or not people actually tried to read the peer-reviewed journal articles (not just the media releases), and if they encountered paywalls when they tried. This is what happened: [Click on the time/date to see the conversation] In case you don't want to read through the whole conversation, … Continue reading Do people outside of universities want to read peer-reviewed journal articles?
I wrote a piece for the Guardian's Higher Education Network, all about the power of "no". The piece was designed particularly with early-career researchers in mind, but there might be some resonance for researchers at other stages of their careers, and maybe even more widely.I always struggle with turning down requests, which tends to make … Continue reading How to do work-life balance: learn to say “no”
Upulie Divisekera, prolific tweeter and all-around awesome scientist, wanted to write a thing about open access and was nice enough to ask me for some help. The result, which you can find on Crikey and read for free, captures the costs of publishing and the avenues through which journal publishers make obscene operating profits. Long story … Continue reading On open access – practical issues
I've taken a little while to get this post done because I've been waiting for my recently-published article to go from online-first to being citeable with volume and page numbers. Last year, I was asked to write an editorial on the topic of industry influence on clinical evidence for the Journal of Epidemiology & Community Health, … Continue reading Introducing evidence surveillance as a research stream
I co-wrote a piece for The Conversation about a new article that was published in the Cochrane Database of Systematic Reviews, written by Andreas Lundh and other luminaries from the research area. The authors showed that industry sponsored clinical trials more often report positive outcomes and fewer harmful side effects. The most interesting result from … Continue reading Dealing with industry’s influence on clinical evidence